VisionWave Seeks Approval for Massive Dilution: 2B Authorized Shares, $40M Offering at Up to 80% Discount
VWAV is trading near its 52-week low of $3.9 (4.6% above the low).
Summary
VisionWave seeks stockholder approval for a package that could increase authorized shares 13-fold, enable a $40M offering at up to 80% discount with warrant resets, and reduce Yorkville's conversion floor to $1.00 — potentially leaving existing holders with under 2% of the company.
Key Events · Financing and Capital Events · VWAV
-
Authorized Shares Increase to 2 Billion
Proposal 1 seeks to increase authorized common stock from 150,000,000 to 2,000,000,000 shares — a 13.3x increase — to satisfy Yorkville reservation obligations, the new equity plan, and the potential $40M offering.
-
$40M Offering at Up to 80% Discount
Proposal 5 authorizes up to $40,000,000 in offerings at a maximum 80% discount to the Nasdaq Minimum Price, with warrants that can reset to 25% of Minimum Price and zero cash exercise provisions, capped at 760,000,000 shares.
-
Yorkville Floor Price Reduced to $1.00
Proposal 4 removes the Exchange Cap and reduces the conversion floor price on Yorkville notes and debentures to $1.00 per share, which could result in issuance of approximately 20 million or more shares.
-
New 100M Share Equity Plan
Proposal 3 reserves 100,000,000 shares for the 2026 Employee Incentive Plan, representing approximately 92.6% of outstanding shares on a fully diluted basis.
Analysis · VWAV · Technology
Shareholders are being asked to approve a package that would fundamentally reshape VisionWave's capital structure. The proposals include increasing authorized shares from 150 million to 2 billion, authorizing a reverse split of up to 1-for-1,000, reserving 100 million shares for a new equity plan, removing the Yorkville exchange cap with a $1.00 conversion floor, and approving a $40 million offering at up to 80% discount to the Nasdaq Minimum Price with warrant resets to 25% of that price. The filing itself illustrates that a $40 million offering at $5.00 per share with warrants reset to $1.25 could result in approximately 168 million shares issued — over 5,000% of the current 3.2 million shares outstanding — leaving existing holders with roughly 1.9% of the company. The company states it does not have sufficient cash to repay obligations maturing in Q1 2027, and that failure to approve these proposals could trigger defaults and going-concern issues. This is a survival financing package with extreme dilution terms, filed while the stock trades near its 52-week low of $3.90.
How filings like this one have moved
In the 30 days to Oct 14, 2026, 43.8% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.48%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VWAV was trading at $4.08 on NASDAQ in the Technology sector, with a market capitalization of approximately $9.6M. The 52-week trading range was $3.90 to $316.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.